The CLRN1 gene gives cells instructions for a protein that supports hearing, vision, and balance, especially in the inner ear and the retina at the back of the eye. This gene helps your body keep sound sensing and light sensing cells working properly. If the protein does not work well, people may develop gradual hearing loss, night blindness, narrowing side vision, and sometimes balance problems. Certain harmful variants in both copies of the CLRN1 gene are linked to Usher syndrome type 3.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others are involved mainly in controlling when certain processes happen, where they take place, and how active they are. Taken together, genes affect how your body grows and works, and they can influence how you react to food, stress, or medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
CLRN1Gene function
What if the gene works
The CLRN1 gene helps inner ear hair cells and retinal cells work properly. Its protein supports the structure and signaling these cells need for hearing, balance, and vision.
Risk
What if the gene does not work
Variants in the CLRN1 gene most often cause Usher syndrome type 3A, with progressive hearing and vision loss; balance problems may occur. Milder or more severe variants can affect when symptoms start, how fast they progress, and which features appear.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the CLRN1 gene does not currently have a CLRN1-specific treatment or drug selection approach in clinical guidelines. The CLRN1 gene is being studied as a target for experimental gene therapy for CLRN1-related vision and hearing loss.
Conditions associated with CLRN1
Gene function
What if the gene works
Hearing and vision depend on sensory cells that must stay well organized and send clear signals. The CLRN1 gene helps support these cells, especially inner ear hair cells and light sensing cells in the retina. This helps explain how the CLRN1 gene supports hearing and vision in day to day life.
CLRN1 makes a protein that sits in the cell membrane of specialized sensory cells. It helps keep important proteins arranged at the cell surface so those cells can work in a stable, coordinated way.
In inner ear hair cells, the CLRN1 gene supports stereocilia (tiny hairlike projections). These projections need the right shape and spacing to turn sound movement into signals the brain can use.
CLRN1 also helps sensory cells manage synapses (the contact points where cells pass messages). This supports smooth communication from hearing and vision cells to nearby nerves.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the CLRN1 gene often make the clarin 1 protein unstable, misshapen, or unable to reach the cell surface, which weakens its interactions inside sensory cells. Milder variants may leave some protein activity, while more severe variants can greatly reduce or stop it. This helps explain how CLRN1 gene variants affect hearing and vision, with lower activity often linked to earlier or more noticeable features.
How variants are linked to conditions
Pathogenic variants in the CLRN1 gene cause Usher syndrome type 3, a condition with progressive hearing loss and vision loss from retinitis pigmentosa, and sometimes balance problems. Some variants in the CLRN1 gene have also been reported in people with retinitis pigmentosa without hearing loss, though the clearest and best-established CLRN1 gene and Usher syndrome type 3 link is this inherited syndromic form.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely seen across the population. Most do not directly affect health and are simply one part of normal human diversity. For many genes, having a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the CLRN1 gene itself. For many living with a CLRN1 change, risk depends more on the exact variant inherited and family history than on lifestyle or environmental factors, and a doctor or genetic counselor can help explain personal risk.
Inheritance of CLRN1 variants
CLRN1 inheritance is usually autosomal recessive. This means a person typically inherits one CLRN1 gene variant from each parent. If both parents carry one variant, each pregnancy has a 25% chance of a child with a CLRN1-related condition, a 50% chance of a child who is a carrier, and a 25% chance of a child who inherits neither variant. Mothers and fathers pass CLRN1 variants on equally.
What does my CLRN1 result mean for my family?
For families with a disease-causing CLRN1 result, the pattern is usually recessive. This often means parents are healthy carriers, brothers and sisters may also be affected or be carriers, and other close relatives may carry the same change. Children of someone with CLRN1-related disease are usually carriers unless the other parent also carries a CLRN1 change.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CLRN1 variants uses a blood or saliva sample to read the CLRN1 gene and look for DNA changes linked to inherited conditions. Results may help confirm a diagnosis, clarify carrier status, or show that no clearly harmful variant was found.
When should I consider getting a genetic test?
Testing for changes in the CLRN1 gene may be worth considering if hearing loss gets worse over time, especially when balance problems or later vision changes, such as trouble seeing at night, are also present. It can also help clarify a family history of combined hearing and vision loss, including Usher syndrome.
A genetic result is only one part of your health story
Genetic findings can provide useful insight, but how much they reveal depends on the condition and the specific variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered along with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than for another. This is a common part of human biology and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It looks at gene and drug patterns to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the CLRN1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines work for you, so any medication concerns or new health symptoms are best discussed with your doctor, especially before starting or changing treatment.
History
Across cultures and time periods, inherited patterns were noted in families with combined hearing and vision changes, especially in groups later recognized to have Usher syndrome type 3. In the 1990s, researchers traced this form of inherited hearing and vision loss to a region on chromosome 3, helped in part by studies of Finnish families where the condition was more common. Building on this early work, scientists identified the CLRN1 gene in 2002 as the key gene involved. That discovery helped separate Usher syndrome type 3 from other forms of Usher syndrome at the genetic level. Over time, descriptions became more precise as additional CLRN1 variants were reported in families from different parts of the world. These findings shaped today’s understanding of this inherited condition and its history.